SJSeyyed Mehdi Jafari

Seyyed Mehdi Jafari

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Seyyed Mehdi Jafari has a total of 53 co-authors. Here are the top co-authors by number of shared publications:

  • Jahanbakhsh Asadi

    Metabolic Disorders Research Center, Biomedical Research Institute, Golestan University of Medical Sciences, Gorgan, Iran

    6 shared publications
  • Marie Saghaeian Jazi

    Metabolic Disorders Research Center, Biomedical Research Institute, Golestan University of Medical Sciences, Gorgan, Iran

    6 shared publications
  • Marie Saghaeian Jazi

    Metabolic Disorders Research Center, Biomedical Research Institute, Golestan University of Medical Sciences, Gorgan, Iran

    5 shared publications
  • Jahanbakhsh Asadi

    Metabolic Disorders Research Center, Biomedical Research Institute, Golestan University of Medical Sciences, Gorgan, Iran

    4 shared publications
  • Zeinab Mohammadi

    Metabolic Disorders Research Center, Biomedical Research Institute Golestan University of Medical Sciences, Gorgan, Iran; Department of Biochemistry and Biophysics, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan, Iran

    4 shared publications
  • Afsaneh Shafiei

    Department of Clinical Biochemistry, School of Medicine, Iranshahr University of Medical Sciences, Iranshahr, Iran

    3 shared publications

Latest Publications

  • Comparison of asprosin and vaspin serum levels in coronary artery disease patients before and after coronary artery bypass graft surgery

    by Dunya Ali Hussein Isawi, Maryam Abolghasemi, Hossein Pourghadamyari, Mahsa Mahdizadeh, Zohreh Ramezani Karim, Seyyed Mehdi Jafari

    Purpose Coronary artery bypass graft (CABG) using cardiopulmonary bypass (on-pump CABG) is frequently linked to postoperative complications via inducing inflammatory responses. Researchers investigated the response patterns of some adipokines in coronary artery disease (CAD) patients who underwent CABG. This study aimed to compare the changes in asprosin and vaspin levels in CAD patients before and after CABG surgery and evaluate the correlation of asprosin and vaspin changes with biochemical factors. Methods This study was conducted on 38 CAD patients undergoing on-pump CABG surgery. The levels of asprosin and vaspin in the serum samples of patients one day before CABG surgery and 45 days after surgery were measured by ELISA kits. Biochemical parameters including fasting blood sugar, triglycerides, total cholesterol, high-density lipoprotein-cholesterol, urea, and creatinine were determined by the autoanalyzer. Cardiac troponin I levels were measured by enzyme-linked fluorescent assay by the VIDAS device. Data were analyzed using SPSS software. Results Asprosin and vaspin levels decreased significantly after surgery compared to before surgery (P < 0.001 and P < 0.001, respectively). Vaspin changes had a statistically significant moderate correlation with total cholesterol and low-density lipoprotein-cholesterol levels of the patients before surgery (r = 0.385, P = 0.017, and r = 0.391, P = 0.015, respectively). Also, asprosin changes had a statistically significant moderate correlation with cardiac troponin I of patients before surgery (r = 0.343, P = 0.035). Conclusion The results of this study illustrated that the levels of asprosin and vaspin reduced after surgery compared to before surgery in CAD patients undergoing CABG surgery.

    • 1 November 2025
      • Vol. 50  (11) , 754-761
    Open Access

    Comparison of Fibrillin-1 and Fibrillin-2 Gene Expression Level in Esophageal Squamous Cell Carcinoma Tumor Tissue and Tumor Margin Tissue

    by Mahsa Mahdizadeh, Marie Saghaeian Jazi, Seyyed Mostafa Mir, Seyyed Mehdi Jafari

    Esophageal cancer is one of the most devastating cancers of the gastrointestinal tract. We will compare the expression levels of fibrillin-1 (FBN1) and fibrillin-2 (FBN2), a family of extracellular matrix glycoproteins, in esophageal cancer with normal adjacent tumor tissue. In this cross-sectional study, 22 esophageal squamous cell carcinoma (ESCC) tumor samples and their matched adjacent normal tissues were collected from hospitals in Gorgan City (Golestan, Iran) between 2020 and 2022. After RNA extraction and cDNA synthesis, we measured the semi-quantitative gene expression level using real-time polymerase chain reaction (PCR). Data from this study were analyzed using SPSS software (version 18), and results were considered statistically significant when the P was <0.05. The primary statistical analyses used in this study were the Paired Samples t test and the Wilcoxon signed-rank test. The expression of the FBN1 gene decreased in tumor tissue compared to normal tissue (the FBN1 gene fold change=0.5472±0.149, P=0.007), and the FBN2 gene expression increased in tumor tissue compared to normal tissue (the FBN2 gene fold change=7.341±1.299, P<0.0001). We found no significant association between FBN1 and FBN2 gene expression and the clinicopathological features. The change in FBN1 and FBN2 expression levels in the tumor tissue compared to normal tissue in ESCC suggests that FBN1 and FBN2 genes can be considered therapeutic targets for ESCC.

  • Overexpression of adenosine receptor (A1, A2a, A2b, A3) genes in esophageal tumor tissue: A2b adenosine receptor as a potential biomarker and anticancer target

    by Mahmood Poorjam, Marie Saghaeian Jazi, Jahanbakhsh Asadi, Alireza Norouzi, Abdolsamad Gharavi, Seyyed Mehdi Jafari

    Esophageal cancer is the eighth most common cancer, the third most common gastrointestinal cancer, and the leading cause of cancer death worldwide. Adenosine receptor signaling is one of the important pathways that have been recently found to be dysregulated in some cancers. Adenosine receptors are divided into four subgroups: A1, A2a, A2b, A3, and here in the current study, we aimed to investigate their association with esophageal cancer. The results showed that the expression level of adenosine receptor genes A1, A2a, A2b, and A3 in esophageal tumor tissue was increased 5.02, 4.22, 9.36, and 3.90 times compared to tumor margin tissue, respectively (p < 0.05). According to the comparison of these values, the A2b receptor gene has the highest overexpression in esophageal tumor samples. There was no significant relationship between adenosine receptor gene expression and age, grade, and tumor size of patients with esophageal cancer. Our data also indicated that adenosine-induced cell death was inhibited by the A2B adenosine receptor antagonist (PSB 603). Finally, our results showed an increase in the expression of all four adenosine receptors in tumor tissue relative to the tumor margin, and the pattern of adenosine receptor expression (A2b > A1 > A2a > A3) shows that the A2b receptor is probably more important than the other adenosine receptors regarding the overexpression level and adenosine-mediated cell death in esophageal cancer cells.

  • Open Access

    Expression changes in the fibulin family in gastric cancer: A Systematic Review

    by Mahsa Mahdizadeh, Zeinab Mohammadi, Seyyed Mehdi Jafari

    Background: Gastric cancer (GC) is one of the most widespread gastrointestinal tumors worldwide, with mortality rates among the highest. Globally, we face more than one million newly diagnosed stomach cancer patients every year. Various factors are closely associated with the formation of GC. One of these factors is the change ...

  • Open Access

    Evaluation of Serum CTRP-4 and CTRP-12 Levels in Hashimoto's Thyroiditis Patients: A Comparative Analysis with a Control Group and Their Correlation with Biochemical Factors

    by Doaa Jawad Al-Husseini, Mohsen Saravani, Shahin Nosratzehi, Hamideh Akbari, Afsaneh Shafiei, Seyyed Mehdi Jafari

    Background & Objective: Hashimoto's thyroiditis (HT) is one of the most common thyroid disorders and is characterized by manifestations attributed to thyroid gland damage and inflammatory conditions. Disturbances in thyroid hormones have physiological effects on lipoprotein metabolism and liver enzymes. CTRP family: C1q/TNF-related protein (CTRP) is an adipokine superfamily of proteins. Its essential role is anti-inflammatory activation, insulin sensitization, and regulation of blood lipids. In this study, we investigated the levels of CTRP-4 and CTRP-12 in the serum of HT patients and determined their association with biochemical factors.Methods: The study included 60 participants, divided into HT patients and control groups. Diagnostic criteria for HT patients included anti-thyroid peroxidase antibodies (anti-TPO)>50 IU/mL. Serum levels of CTRP-4, CTRP-12, and anti-TPO were measured using an Enzyme-Linked Immunosorbent Assay.Results: Our findings showed that the CTRP-4 and CTRP-12 levels in HT patients were higher than in the control groups (P=0.012 and P=0.003, respectively). HT patients also exhibited higher fasting blood glucose (FBG), cholesterol, TG, HDL, and LDL serum levels. Spearman's correlation analysis revealed a positive association between serum levels of CTRP-4 and CTRP-12 and anti-TPO (respectively, r= 0.295, P=0.022 and r = 0.346, P=0.007).Conclusion: Our findings showed that the CTRP-4 and CTRP-12 levels in HT patients were higher than those in the control groups. These factors probably play a role in the pathogenesis of Hashimoto's thyroiditis. The clinical significance of these factors should be evaluated in future studies.


  • Open Access

    Investigating the relationship between serum zinc levels and red blood cell indices in anemic patients referred to the laboratories in Gorgan, Iran

    by Zahra Eslami, Shayan Marhamaty, Seyyed Mehdi Jafari, Mohadese Khorasani, Mehdi Sheikh Arabi, Hamidreza Joshaghani

    Background: Bivalent minerals function as crucial cofactors that participate in a multitude of metabolic pathways within the organism. Specifically, zinc (Zn) assumes catalytic, structural, and regulatory roles in numerous biological processes. A severe deficiency in Zn can lead to disruptions in nucleic acid and protein synthesis, impaired cellular proliferation, increased apoptosis, and ...

  • Evaluation of the serum level of CTRP-3 and CTRP-6 in patients with Hashimoto’s disease and correlation with thyroid hormones and lipid profile

    by Rafal Sameer Al-Abboody, Nadia Heydari, Mohsen Saravani, Shahin Nosaratzehi, Hamideh Akbari, Seyyed Mehdi Jafari

    Objectives: Numerous studies show that the adipokines play a role in on the thyroid axis. The aim of this study was the evaluation of serum level of CTRP-3 and CTRP-6 as a member of the adipokines family in patients with Hashimoto’s. Methods: The levels of CTRP-3 and CTRP-6 were evaluated with enzyme-linked immunosorbent assay in 70 subjects (35 newly diagnosed Hashimoto’s thyroiditis and 35 healthy subjects). Their relationship with the thyroid hormone and some biochemical factors was analyzed. Results: The levels of CTRP3 and CTRP6 in patients with Hashimoto’s disease were higher than those in the control group (p<0.05). There was a significant positive correlation between CTRP3 and TSH levels (r=0.286 and p=0.017). There was a significant relationship between CTRP3 and Fasting Blood Sugar (r=0.249 and p=0.038). There was a significant inverse negative correlation between CTRP6 levels and T3 (r=−0.269 and p=0.024), and T4 (r=−0.272 and p=0.023). Moreover, there was a significant positive correlation between CTRP6 serum levels and TSH serum levels (r=0.397 and p=0.001). There was a significant positive correlation between CTRP6 levels and Cholesterol (r=0.351 and p=0.003), and LDL (r=−0.244 and p=0.042). Conclusions: Finally, our results demonstrated that serum levels of CTRP3 and CTRP6 are higher in patients with Hashimoto’s compared to the control group and probably play a role in the pathogenesis of Hashimoto’s thyroiditis.


  • Open Access

    Midazolam enhances osteogenic differentiation of human bone marrow mesenchymal stem cells

    by Zeinab Mohammadi, Marie Saghaeian Jazi, Seyyed Mehdi Jafari, Seyed Mostafa Mir, Massoud Amanlou, Jahanbakhsh Asadi

    Background: Bone remodeling involves a balance between osteoblast-driven formation and osteoclast-mediated resorption, with disruptions leading to diseases like osteoporosis. Midazolam (MDZ), known for its sedative properties, has shown effects on cellular differentiation and hydroxyapatite formation in dental cells. However, its role in promoting osteogenic differentiation in human bone marrow mesenchymal stem ...

  • Open Access

    Changes in Claudin-4 expression and tight junction integrity in human esophageal cancer: A Systematic Review

    by Mahsa Mahdizadeh, Zahra Arab-Bafrani, Seyyed Mehdi Jafari

    Background: Esophageal cancer is one of the most common cancers worldwide. Because this disease is usually diagnosed in advanced stages, its treatment is challenging and the survival rate of patients is relatively low. One of the parts that is disturbed in the tumor tissue of esophageal cancer is the tight ...

  • Overexpression of Discoidin Domain Receptor 1 Is Associated with Tumor Size in Esophageal Squamous Cell Carcinoma

    by Afsaneh Shafiei, Seyyed Mehdi Jafari, Marie Saghaeian Jazi, Mahmoud Pourjam, Jahanbakhsh Asadi

    Background. Discoidin domain receptor 1 (DDR1) is confirmed as a member of the transmembrane receptor tyrosine kinase (RTK) superfamily, which plays an influential role in various cancers. Increasing evidence has suggested that DDR1 is plays role in cancer progression and metastasis. However, DDR1 function and the underlying mechanism of DDR1 receptor signaling pathways is largely unknown, especially in esophageal squamous cell carcinoma (ESCC). Methods and results. We obtained 42 paired samples of ESCC tumors (N = 21) and adjacent normal tissues (N = 21) from newly diagnosed ESCC patients. In this study, the expression of DDR1 in esophageal cancer was retrieved based on the GENT2, OncoDB databases. AlsoqRT-PCR experiments was used to measure DDR1 expression experimentally in ESCC tissues compared to adjacent non-tumor tissues (NTs). Moreover, the correlation between the expression of DDR1 and clinic pathologic factors was analyzed. The diagnostic significance of the results was subsequently evaluated utilizing the receiver operating characteristic (ROC) curve. The result showed that mRNA expression of DDR1 was up-regulated in ESCC tissues compared with NTs (p = 0.0001). Statistical analysis revealed that DDR1 expression was significantly higher in samples with a tumor size of more than five centimeters (p = 0.02). The ROC curve analysis indicated that DDR1 expression level in tissue potentially have high accuracy for diagnosing ESCC compared with adjacent non-tumor tissues NTs (AUC = 0.92, Specificity = 84%, sensitivity = 96%). Conclusions. Our findings suggest that overexpression of the DDR1 might play a function in promoting cancer and tumor size. Moreover, DDR1 can potentially act as a novel biomarker for identifying ESCC patients, indicating the potential of this receptor for ESCC-targeted therapeutics.